Evidence map›Paper›PMID 26617895›Full record

ArticleInternational journal of clinical and experimental pathology2015

Serum cytokine, chemokine and hormone levels in Saudi adults with pre-diabetes: a one-year prospective study.

Nasser M Al-Daghri, Abdulrahman Sm Al-Ajlan, Hanan Alfawaz, Sobhy M Yakout, Naji Aljohani, Sudhesh Kumar, Majed S Alokail

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Hydroalcoholic Extract ofIranian journal of pharmaceutical research : IJPR
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Nasser M Al-DaghriDepartment of Biochemistry, Prince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia ; Department of Biochemistry, Biomarkers Research Program, College of Science, King Saud University Riyadh 11451, Saudi Arabia.
Abdulrahman Sm Al-AjlanCollege of Applied Medical Sciences, Department of Clinical Laboratory Sciences, King Saud University Riyadh, P.O. Box 10219, Riyadh 11433, Saudi Arabia.
Hanan AlfawazDepartment of Biochemistry, Prince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia ; Department of Food Science and Nutrition, College of Food Science and Agriculture, King Saud University Riyadh 11451, Saudi Arabia.
Sobhy M YakoutDepartment of Biochemistry, Prince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia ; Department of Biochemistry, Biomarkers Research Program, College of Science, King Saud University Riyadh 11451, Saudi Arabia.
Naji AljohaniDepartment of Biochemistry, Prince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia ; Specialized Diabetes and Endocrine Center, College of Medicine, King Fahad Medical City and King Saud bin Abdulaziz University for Health Sciences Riyadh 22490, Saudi Arabia.
Sudhesh KumarWarwick Medical School, Clinical Sciences Research Laboratories, University Hospitals Coventry and Warwickshire Trust Coventry CV2 2DX, United Kingdom.
Majed S AlokailDepartment of Biochemistry, Prince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia ; Department of Biochemistry, Biomarkers Research Program, College of Science, King Saud University Riyadh 11451, Saudi Arabia.
King Saud University · SAKing Saud bin Abdulaziz University for Health Sciences · SAKing Saud Medical City · SAUniversity Hospital Coventry · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 5-10% of subjects with pre-diabetes eventually progress to diabetes every year. While inflammation is thought to be involved in the development of obesity-related type 2 diabetes mellitus (T2DM), the relation between inflammation and pre-diabetes remains largely unexplored. In this study we examined a comprehensive panel of 10 serum biomarkers involved in overweight and obese subjects with pre-diabetes. A total of 98 subjects (23 males, 75 females) were advised to reduce total intake of fat, increase fiber intake and physical activity. Serum cytokines, MCP and other hormones were assessed by multiplex cytokine profiling. Results show that CRP, IL-6, leptin, IL-10, MCP, resistin, serpin, and TNF-α were significantly lower after 12-months than baseline. Serum concentrations of other adipocytokines, including adipsin and leptin were modestly lower in the 12-month follow-up than baseline, but failed to reach statistical significance. Changes in HbA1c was found to be positively correlated with adipsin, CRP, IL-6, IL-10, resistin, serpin, and TNF-α. The results suggest that promotion of lifestyle changes for one year among overweight and obese subjects modestly changes several circulating inflammatory biomarkers which maybe favorable in reducing risk for T2DM progression.

Indexed as

AdipokinesAdultBiomarkersChemokinesCytokinesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesHumansInflammationLeptinMaleMiddle AgedObesityOverweightProspective StudiesAdipokinesBiomarkersChemokinesCytokinesLeptincytokinesDMT2follow-upinflammationPre-diabetes

Identifiers

PMID26617895
PMCPMC4637711
OpenAlexW878448311

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.